Hyponatremia in the elderly: Etiologies, implications and therapy

Aging Health

Volumn 7, Issue 5, 2011, Pages 775-785

  Rosner, Mitchell H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

elderly; hyponatremia; pathogenesis; therapy

Indexed keywords

CHLORTALIDONE; CONIVAPTAN; DEMECLOCYCLINE; DESMOPRESSIN; HYDROCHLOROTHIAZIDE; IBUPROFEN; ISOTONIC SOLUTION; LOOP DIURETIC AGENT; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; SODIUM; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; UREA; VASOPRESSIN V2 RECEPTOR;

CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ELDERLY CARE; FALLING; GAIT DISORDER; HUMAN; HYPERTENSION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY TUBULE FUNCTION; NOCTURIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOLOGIC FRACTURE; PATIENT MONITORING; PATIENT SAFETY; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SODIUM BLOOD LEVEL; THIRST; URINE OSMOLALITY; WATER DEPRIVATION; XEROSTOMIA;

EID: 80054103021     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.11.59     Document Type: Review

References (55)

1. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin. Chim. Acta 337(1-2), 169-172 (2003).
2. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am. J. Med. 119(7 Suppl. 1), S30-S35 (2006).
3. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann. Intern. Med. 102(2), 164-168 (1985). (Pubitemid 15157162)
4. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J. Am. Geriatr. Soc. 43(12), 1410-1413 (1995).
5. DeVita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin. Nephrol. 34(4), 163-166 (1990). (Pubitemid 20342876)
6. Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff. Resour. Alloc. 4, 10 (2006).
7. Shea AM, Hammill BG, Curtis LH, Szczech LA, Schulman KA. Medical costs of abnormal serum sodium levels. J. Am. Soc. Nephrol. 19(4), 764-770 (2008).
8. Adrogué HJ, Madias NE. Hyponatremia. N. Engl. J. Med. 342(21), 1581-1589 (2000). (Pubitemid 30340505)
9. Hoorn EJ, Rivadeneira F, van Meurs JB et al. Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J. Bone Miner. Res. 26(8), 18221828 (2011).
10. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101(7), 583-588 (2008). (Pubitemid 351912001)
11. Sandhu HS, Gilles E, DeVita MV, Panagopoulos G, Michelis MF. Hyponatremia associated with large-bone fracture in elderly patients. Int. Urol. Nephrol. 41(3), 733-737 (2009).
12. Kinsella S, Moran S, Sullivan MO, Molloy MGM, Eustace JA. Hyponatremia independent of osteoporosis is associated with fracture risk. Clin. J. Am. Soc. Nephrol. 5(2), 275-280 (2010).
13. Verbalis JG, Barsony J, Sugimura Y et al. Hyponatremia-induced osteoporosis. J. Bone Miner. Res. 25(3), 554-563 (2010).
14. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am. J. Med. 119(1), 71e1-71e8 (2006).
15. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transplant. 21(1), 70-76 (2006). (Pubitemid 43057112)
16. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch. Int. Med. 170(3), 294-302 (2010).
17. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate and severe hyponatremia. Am. J. Med. 122(9), 857-865 (2009).
18. Kumar S, Berl T. Sodium. Lancet 352(9123), 220-228 (1998). (Pubitemid 28329332)
19. Belmin J, Levy BI, Michel JB. Changes in the renin-angiotensin- aldosterone axis later in life. Drugs Aging 5(5), 391-400 (1994). (Pubitemid 2157457)
20. Musch W, Verfaille J, Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate antidiuretic hormone. Clin. J. Am. Soc. Nephrol. 1(5), 909-914 (2006).
21. Musso CG, Macias-Nunez JF. Dysfunction of the thick loop of Henle and senescence: from molecular biology to clinical geriatrics. Int. Urol. Nephrol. 43(1), 249-252 (2011).
22. Hoyle GE, Chua M, Soiza RL. Volaemic assessment of the elderly hyponatraemic patient: reliability of clinical assessment and validation of bioelectrical impedance analysis. QJM 104, 35- (2011).
23. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin. J. Am. Soc. Nephrol. 3(4), 1175-1184 (2008).
24. Verbalis JG. Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol. Nutr. 57(Suppl. 2), 30-40 (2010).
25. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N. Engl. J. Med. 356(20), 2064-2072 (2007). (Pubitemid 46789896)
26. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann. Pharmacother. 40(9), 1618-1622 (2006). (Pubitemid 44330206)
27. Hwang KS, Kim GH. Thiazide-induced hyponatremia. Electrolyte Blood Press. 8(1), 51-57 (2010).
28. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Preve Heart Attack Trial (ALLHAT). JAMA 288(23), 2981-2997 (2002).
29. Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J. R. Soc. Med. 83(11), 704-708 (1990). (Pubitemid 20361564)
30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265(24), 3255-3264 (1991).
31. Sunderam SG, Mankikar GD. Hyponatremia in the elderly. Age Ageing 12(1), 77-80 (1983).
32. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J. Am. Soc. Nephrol. 5(4), 1106-1111 (1994). (Pubitemid 24977088)
33. Weatherall M. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol. Urodyn. 23(4), 302-305 (2004). (Pubitemid 38859418)
34. Schrier RW, Gross P, Gheorghiade M, Berl T; For the SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355(20), 2009-2012 (2006).
35. Barsony J, Sugimua Y, Verbalis JG. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J. Biol. Chem. 286(12), 10864-10875 (2011).
36. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia. Clin. J. Am. Soc. Nephrol. 6(5), 960-965 (2011).
37. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120(Suppl. 11), S1-S21 (2007). (Pubitemid 350027722)
38. Hew-Butler T, Almond C, Ayus JC et al. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005 Clin. J. Sport Med. 15(4), 208-213 (2005).
39. King JD, Rosner MH. Osmotic demyelination syndrome. Am. J. Med. Sci. 339(6), 561-567 (2010).
40. Rose BD. New approach to disturbances in the plasma sodium concentration. Am. J. Med. 81(6), 1033-1040 (1986).
41. Steele A, Gowrishankar M, Abrahamson S, Mazer CD, Feldman RD, Halperin ML. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann. Intern. Med. 126(1), 20-25 (1997). (Pubitemid 27021214)
42. Musch W, Decaux G. Treating the syndrome of inappropriate ADH secretion with isotonic saline. QJM 91, 749-753 (1998). (Pubitemid 28508621)
43. Musch W, Decaux G. Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. Int. Urol. Nephrol. 32(3), 475-493 (2001). (Pubitemid 32825445)
44. Gross P, Reimann D, Henschkowski J, Damian M. Treatment of severe hyponatremia: conventional and novel aspects. J. Am. Soc. Nephrol. 12(Suppl. 17), S10-S14 (2001). (Pubitemid 32119048)
45. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin. J. Am. Soc. Nephrol. 2(6), 1110-1117 (2007).
46. Perianayagam A, Sterns RH, Silver SM et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3(2), 331-336 (2008).
47. Miller PD, Linas SL, Schrier RW. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA 243(24), 2513-2515 (1980). (Pubitemid 10039244)
48. Hantman D, Rossier B, Zohlman R, Schrier RW. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann. Intern. Med. 78(6), 870-875 (1973).
49. Decaux G. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 35(2), 82-88 (1983). (Pubitemid 13033726)
50. Brodsky WA, Rapoport S. The mechanism of polyuria of diabetes insipidus in man; the effect of osmotic loading. J. Clin. Invest. 30(3), 282-291 (1951).
51. Berl T. Impact of solute intake on urine flow and water excretion. J. Am. Soc. Nephrol. 19(6), 1076-1078 (2008).
52. Decaux G, Prospert F, Penninckx R, Namias B, Soupart A. 5 year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea. Nephron 63(4), 468-470 (1993). (Pubitemid 23118960)
53. Robertson GL. Vaptans for the treatment of hyponatremia. Nat. Rev. Endocrinol. 7(3), 151-161 (2011).
54. Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single center experience. Nephrol. Dial. Transplant. 25(5), 1524-531 (2010).
55. Berl T, Quittnat-Pelletier F, Verbalis JG et al. For the SALTWATER investigators. Oral tolvaptan is safe and effective for chronic hyponatremia. J. Am. Soc. Nephrol. 21(4), 705-712 (2010).